Gene-environment interaction in dyslipidemia

Current Opinion in Lipidology

Volumn 26, Issue 2, 2015, Pages 133-138

  Cole, Christopher B ^a   Nikpay, Majid ^a   McPherson, Ruth ^a  

^a UNIVERSITY OF OTTAWA HEART INSTITUTE   (Canada)

Author keywords

coronary artery disease; diet; genetic risk score; obesity; single nucleotide polymorphism

Indexed keywords

HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPID; TRIACYLGLYCEROL;

CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; DIET; DYSLIPIDEMIA; EFFECT SIZE; EXERCISE; FATTY ACID OXIDATION; GENETIC ASSOCIATION; GENETIC RISK; GENETIC VARIABILITY; GENOTYPE ENVIRONMENT INTERACTION; GLUCOSE METABOLISM; HERITABILITY; HUMAN; LIPID BLOOD LEVEL; LIPID COMPOSITION; META ANALYSIS (TOPIC); OBESITY; PHENOTYPE; PRIORITY JOURNAL; REVIEW; SINGLE NUCLEOTIDE POLYMORPHISM; SMOKING; TRIACYLGLYCEROL BLOOD LEVEL; ANIMAL; BLOOD; GENETIC PREDISPOSITION; GENETICS; LIPID METABOLISM; RISK FACTOR;

ADIPOSITY; ANIMALS; CHOLESTEROL, HDL; DYSLIPIDEMIAS; GENE-ENVIRONMENT INTERACTION; GENETIC PREDISPOSITION TO DISEASE; GENOME-WIDE ASSOCIATION STUDY; HUMANS; LIPID METABOLISM; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK FACTORS;

EID: 84952720379     PISSN: 09579672     EISSN: 14736535     Source Type: Journal    
DOI: 10.1097/MOL.0000000000000160     Document Type: Review

References (39)

1. Culverhouse RC, Suarez BK, Beckmann L, et al. Gene by environment interactions. Genet Epidemiol 2007; 31 (Suppl 1):S68-S74.
2. Cole CB, Nikpay M, Lau P, et al. Adiposity significantly modifies genetic risk for dyslipidemia. J Lipid Res 2014; 55:2416-2422.
3. Kim DS, Burt AA, Ranchalis JE, et al. Novel gene-by-Environment interactions: APOB and NPC1L1 variants affect the relationship between dietary and total plasma cholesterol. J Lipid Res 2013; 54:1512-1520.
4. Joseph PG, Pare G, Anand SS. Exploring gene-Environment relationships in cardiovascular disease. Can J Cardiol 2013; 29:37-45.
5. Kang EY, Han B, Furlotte N, et al. Meta-Analysis identifies gene-by-Environment interactions as demonstrated in a study of 4965 mice. PLoS Genet 2014; 10:e1004022.
6. Namboodiri KK, Kaplan EB, Heuch I, et al. The Collaborative Lipid Research Clinics Family Study: biological and cultural determinants of familial resemblance for plasma lipids and lipoproteins. Genet Epidemiol 1985; 2:227-254.
7. Yu Y, Wyszynski DF, Waterworth DM, et al. Multiple QTLs influencing triglyceride and HDL and total cholesterol levels identified in families with atherogenic dyslipidemia. J Lipid Res 2005; 46:2202-2213.
8. Teslovich TM, Musunuru K, Smith AV, et al. Biological, clinical and population relevance of 95 loci for blood lipids. Nature 2010; 466:707-713.
9. Asselbergs FW, Guo Y, van Iperen EP, et al. Large-scale gene-centric metaanalysis across 32 studies identifies multiple lipid loci. Am J Hum Genet 2012; 91:823-838.
10. Willer CJ, Schmidt EM, Sengupta S, et al. Discovery and refinement of loci associated with lipid levels. Nat Genet 2013; 45:1274-1283.
11. Howard BV, Ruotolo G, Robbins DC. Obesity and dyslipidemia. Endocrinol Metab Clin North Am 2003; 32:855-867.
12. Strong A, Ding Q, Edmondson AC, et al. Hepatic sortilin regulates both apolipoprotein B secretion and LDL catabolism. J Clin Invest 2012; 122:2807-2816.
13. Burkhardt R, Toh SA, Lagor WR, et al. Trib1 is a lipid-And myocardial infarction-Associated gene that regulates hepatic lipogenesis and VLDL production in mice. J Clin Invest 2010; 120:4410-4414.
14. Schjoldager KT, Vester-Christensen MB, Bennett EP, et al. O-glycosylation modulates proprotein convertase activation of angiopoietin-like protein 3: possible role of polypeptide GalNAc-Transferase-2 in regulation of concentrations of plasma lipids. J Biol Chem 2010; 285:36293-36303.
15. Johansen CT, Wang J, Lanktree MB, et al. An increased burden of common and rare lipid-Associated risk alleles contributes to the phenotypic spectrum of hypertriglyceridemia. Arterioscler Thromb Vasc Biol 2011; 31:1916-1926.
16. Hegele RA, Ginsberg HN, Chapman MJ, et al. The polygenic nature of hypertriglyceridaemia: implications for definition, diagnosis, and management. Lancet Diabetes Endocrinol 2014; 2:655-666.
17. Futema M, Plagnol V, Li K, et al. Whole exome sequencing of familial hypercholesterolaemia patients negative for LDLR/APOB/PCSK9 mutations. J Med Genet 2014; 51:537-544.
18. Okeefe JH Jr, Cordain L, Harris WH, et al. Optimal low-Density lipoprotein is 50 to 70 mg/dl: lower is better and physiologically normal. J Am Coll Cardiol 2004; 43:2142-2146.
19. Chen Z, Peto R, Collins R, et al. Serum cholesterol concentration and coronary heart disease in population with low cholesterol concentrations. BMJ 1991; 303:276-282.
20. Okeefe JH Jr, Cordain L. Cardiovascular disease resulting from a diet and lifestyle at odds with our Paleolithic genome: how to become a 21st-century hunter-gatherer. Mayo Clin Proc 2004; 79:101-108.
21. Harris WS, Mozaffarian D, Rimm E, et al. Omega-6 fatty acids and risk for cardiovascular disease: a science advisory from the American Heart Association Nutrition Subcommittee of the Council on Nutrition, Physical Activity, and Metabolism; Council on Cardiovascular Nursing; and Council on Epidemiology and Prevention. Circulation 2009; 119:902-907.
22. Johnson RK, Appel LJ, Brands M, et al. Dietary sugars intake and cardiovascular health: a scientific statement from the American Heart Association. Circulation 2009; 120:1011-1020.
23. Smith EN, Kruglyak L. Gene-Environment interaction in yeast gene expression. PLoS Biol 2008; 6:e83.
24. Gagneur J, Stegle O, Zhu C, et al. Genotype-Environment interactions reveal causal pathways that mediate genetic effects on phenotype. PLoS Genet 2013; 9:e1003803.
25. Keller MC. Gene-Environment interaction studies have not properly controlled for potential confounders: the problem and the (simple) solution. Biol Psychiatry 2014; 75:18-24.
26. Duncan LE, Keller MC. A critical review of the first 10 years of candidate geneby-Environment interaction research in psychiatry. Am J Psychiatry 2011; 168:1041-1049.
27. Li S, Zhao JH, Luan J, et al. Physical activity attenuates the genetic predisposition to obesity in 20,000 men and women from EPIC-Norfolk prospective population study. PLoS Med 2010; 7:pii: e1000332.
28. Hellstrand S, Sonestedt E, Ericson U, et al. Intake levels of dietary long-chain PUFAs modify the association between genetic variation in FADS and LDL-C. J Lipid Res 2012; 53:1183-1189.
29. Junyent M, Tucker KL, Smith CE, et al. The effects of ABCG5/G8 polymorphisms on plasma HDL cholesterol concentrations depend on smoking habit in the Boston Puerto Rican Health Study. J Lipid Res 2009; 50:565-573.
30. Liu WY, Yin RX, Zhang L, et al. Interactions of the LIPG 584C>T polymorphism and alcohol consumption on serum lipid levels. Alcohol 2011; 45:681-687.
31. Lu Y, Feskens EJ, Dolle ME, et al. Dietary n-3 and n-6 polyunsaturated fatty acid intake interacts with FADS1 genetic variation to affect total and HDLcholesterol concentrations in the Doetinchem Cohort Study. Am J Clin Nutr 2010; 92:258-265.
32. Smith CE, Arnett DK, Tsai MY, et al. Physical inactivity interacts with an endothelial lipase polymorphism to modulate high density lipoprotein cholesterol in the GOLDN study. Atherosclerosis 2009; 206:500-504.
33. Tan A, Sun J, Xia N, et al. A genome-wide association and gene-Environment interaction study for serum triglycerides levels in a healthy Chinese male population. Hum Mol Genet 2012; 21:1658-1664.
34. Wu Y, Marvelle AF, Li J, et al. Genetic association with lipids in Filipinos: waist circumference modifies an APOA5 effect on triglyceride levels. J Lipid Res 2013; 54:3198-3205.
35. Mosher MJ, Lange LA, Howard BV, et al. Sex-specific interaction between APOE genotype and carbohydrate intake affects plasma HDL-C levels: the Strong Heart Family Study. Genes Nutr 2008; 3:87-97.
36. Ouellette C, Rudkowska I, Lemieux S, et al. Gene-Diet interactions with polymorphisms of the MGLL gene on plasma low-Density lipoprotein cholesterol and size following an omega-3 polyunsaturated fatty acid supplementation: a clinical trial. Lipids Health Dis 2014; 13:86.
37. Carvalho-Wells AL, Jackson KG, Lockyer S, et al. APOE genotype influences triglyceride and C-reactive protein responses to altered dietary fat intake in UK adults. Am J Clin Nutr 2012; 96:1447-1453.
38. Beer NL, Tribble ND, McCulloch LJ, et al. The P446L variant in GCKR associated with fasting plasma glucose and triglyceride levels exerts its effect through increased glucokinase activity in liver. Hum Mol Genet 2009; 18:4081-4088.
39. Grosskopf I, Baroukh N, Lee SJ, et al. Apolipoprotein A-V deficiency results in marked hypertriglyceridemia attributable to decreased lipolysis of triglyceriderich lipoproteins and removal of their remnants. Arterioscler Thromb Vasc Biol 2005; 25:2573-2579.